Presentations, studies and new products discussed single-cell sequencing
One of the more interesting developments in molecular spectroscopy over the past 10 years has been the introduction of spectrometers designed for use with small samples, generally on the order of a microliter. The need for such devices stems primarily from life science researchers. Foremost among the applications that have been enabled by these instruments […]
Agilent Shines Agilent Technologies topped fiscal second quarter expectations as sales climbed 5.8%, 8.0% organically, to $1.0 billion. Currency headwinds and divestments impacted sales growth by 1.3% and 0.8%, respectively. Organic sales were driven by strong double-digit growth in China, especially in food and biopharmaceutical markets. Sales further benefited from enhanced revenue cycle times as […]
Company Announcements Cepheid’s 2015 Non-Clinical revenue declined 1.2% to $28.7 million, or 5% of total revenues. North America Non-Clinical sales grew 11.0% to $27.6 million due to increased grant and collaboration revenues. International Non-Clinical sales fell 75.0% to $1.0 million. Non-Clinical revenue is also expected to decline in 2016. In February, Cepheid named Warren Kocmond, […]
Company Announcements Sartorius 2015 sales grew 25.1%, 16.0% organically, to €1.1 billion ($1.2 billion) (see IBO 4/15/16). Adjusted operating profit grew 52.5% to €204.9 million ($227.7 million). Lab Products & Services (LPS) revenue increased 5.0% excluding currency to €305.5 million ($339.5 million), with sales in Asia Pacific, EMEA and the Americas up 11.4%, 2.9% and […]
Company Announcements Spark Holland added Axel Semrau as a “Value Added Partner” for Switzerland and Austria. The companies have worked together for five years in Germany. In May, Purigen Biosystems completed an $18.2 million Series A financing from 5AM Ventures and Roche Venture Fund. The company plans to commercialize an isotachophoresis-based benchtop system for automated […]
The migration from HPLC to UHPLC continues to fuel growth in the overall LC market, with performance, workflow and productivity enhancements driving end-user purchases. LC manufacturers are making the transition for end-users somewhat seamless, particularly with the expansion of column chemistries, including the use of sub–2 µm, sub–3 µm and superficially porous particles (core shell) […]
US equity markets advanced in May in spite of the US Federal Reserve’s implications to raise interest rates in June. On the economic front, first quarter US GDP growth projections were raised 30 basis points to 0.8%, led by continued strength in consumer spending and a strong housing market. However, the tepid economic growth was […]
London, UK 5/23/16; Stansted, UK 5/23/16; London, UK 5/25/16—Publicly held Elektron Technology, a supplier of engineered products for companies that connect, monitor and control, has sold its Agar Scientific business to management and private equity group Foresight Group for £2.3 million ($3.4 million = £0.68 = $1) in cash. Foresight Group invested £1.9 million ($2.8 […]
New York, NY 5/16/16—Enzo Life Sciences, a subsidiary of Enzo Biochem, will receive a $35 million payment as part of a settlement with Thermo Fisher Scientific (formerly Life Technologies) in its suit alleging infringement of US Patents Nos. 6,992,180 (Oligo- or Polynucleotides Comprising Phosphate Moiety Labeled Nucleotides) and 7,064,197 (System, Array and Non-Porous Solid Support […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
